Due to the rarity of generalized pustular psoriasis, cases often go unrecognized by physicians who are not dermatologists.
All articles by Tori Rodriguez, MA, LPC, AHC
Methods to prevent and treat COVID-19 in patients with cancer have had to evolve alongside the SARS-CoV-2 virus.
Cynthia F. Griffith, MPAS, PA-C, and Peter A. Young, MPAS, PA-C, discuss the challenges faced by physician assistants in dermatology practice.
An ACAAI expert panel issued recommendations for eliminating racial disparities in the treatment of atopic dermatitis and food allergies in children with skin of color.
Robyn Tiger, MD, radiologist and founder of StressFreeMD, talks about physician burnout and strategies for addressing stress-related illness.
This overview provides insight into the alcohol-psoriasis connection and offers recommendations for clinicians when discussing this topic with patients.
To learn more about the escalating public health problems created by street drug xylazine, as well as treatment implications for clinicians, we interview hospital medicine specialist Varun Malayala, MD, MPH, FACP, FHM, and Edward C. Traver, MD.
Patients with hidradenitis suppurativa (HS) have a greater prevalence of rheumatoid arthritis (RA), spondyloarthritis (SpA), and psoriatic arthritis (PsA); we discuss these relationships with experts Louis Bridges, Jr., MD, PhD, and Saakshi Khattri, MD.
Experts discuss the challenges and potential resolutions for increasing diversity of clinical trial study populations.
We spoke with dermatologist Emily Gurnee, MD, about her experiences treating atopic dermatitis in children and educating their caretakers.
The causes for, and ways to improve, the diagnostic delays in patients with psoriasis who progress to psoriatic arthritis are discussed.
Margareth Pierre-Louis, MD, MBA, FAAD discusses issues pertaining to skin cancer in people with skin of color as well as recommendations for the provision of multi-ethnic dermatology care.
Even though it is often thought of as a skin condition, many forms of epidermolysis bullosa are truly multisystem disorders, which makes coordinating the care complex.
Clinician competence in treating patients of various racial and ethnic backgrounds and the critical need for greater inclusion of diverse populations in trials investigating the pathophysiology and treatment of AD are underscored.
The pressing need to clarify risk factors and effective interventions for skin of color populations is underscored.
A roundtable discussion by experts in issues facing patients with skin of color reveals interesting insights.
Bioprinting for burns and other severe wounds could significantly accelerate wound closure and healing, reduce the risk for infection and minimize scarring.
The off-label use of treatments is especially prevalent in dermatology as the need for effective therapies outpaces the approval process. Experts discuss the most commonly employed treatments, the ethical implications of off-label use, and the need for patient education.
Katlein França, MD, PhD, spoke with Dermatology Advisor about the use of the behavior therapy technique “habit reversal training” (HRT) for the treatment of trichotillomania, excoriation disorder, and itch.
Atopic dermatitis, especially severe atopic dermatitis, is associated with allergic, autoimmune, and cardiovascular comorbidities.
There has been ongoing controversy regarding the relative safety of e-cigarettes vs combustible cigarettes.
Dermatology Advisor interviewed Raja Sivamani, MD, MS, AP, adjunct associate professor of clinical dermatology and director of clinical research at the University of California to discuss the application of ayurvedic medicine in dermatology.
Experts discuss their treatment strategies – and promising therapies – for treatment-resistant atopic dermatitis
According to estimates from the National Institutes of Health, androgenic alopecia affects 30 million women and 50 million men in the United States.